Recursion Pharmaceuticals Summit Therapeutics: 2026 Insight
Two biotech contenders, Recursion Pharmaceuticals and Summit Therapeutics, face off in a year of uncertainty and oppo...
Discover when it’s advisable to keep cash instead of opting for bank deposits. This information will help you manage your money wisely.
23,560 articlesTwo biotech contenders, Recursion Pharmaceuticals and Summit Therapeutics, face off in a year of uncertainty and oppo...
Two transforming icons, Caterpillar and Walmart, are competing for a place in 2026 portfolios. The question: which tr...
GE Vernova arrives at its July 22 earnings with a $163 billion backlog and raised targets, signaling a strong beat ri...
A high-profile PR moment becomes a money lesson. This article breaks down how apology politics affect fame and fortun...
Gap reports eight straight quarters of positive comps and a multi-decade margin high, prompting a televised reaction ...
A sharp, near-$99 million exit from this cybersecurity stock has analysts buzzing about a possible shift in investor ...
Analysts push a higher target for NVIDIA as demand for Blackwell and Vera Rubin accelerates. The latest guidance sign...
IonQ is set to release Q1 2026 results after the bell, with investors weighing growth across five acquisitions, a Sky...
Three ETFs can deliver roughly $37,000 a year on a $500,000 portfolio, providing about $3,100 a month without selling...
Oracle is leaning into AI infrastructure with its database expertise, cloud platform, and data-center plans. This art...
With bond yields near change around 5%, an early-retiree case study shows how a shift in income from bonds alters the...
A one-time SSA option lets retirees undo a Social Security claim within 12 months, potentially lifting monthly checks...